Align Technology (ALGN) Q1 2024: Systems and Services Surge 17.5%, Powering Upgraded Growth Outlook
Systems and services revenue outpaced expectations, prompting Align to raise its full-year growth outlook and signal a new phase of digital innovation. A stable global demand environment, robust product launches, and expanding partnerships with DSOs underpin management’s confidence for the remainder of 2024.
Summary
- Systems and Services Acceleration: Upgraded scanner and service offerings are driving above-trend segment growth.
- Market Stability Persists: Broad-based demand steadiness supports ongoing investments in product and channel expansion.
- Innovation Pipeline Gains Traction: New product launches and DSO partnerships anchor management’s bullish outlook.
Business Overview
Align Technology designs and manufactures clear aligners (Invisalign) and digital dental scanning systems (iTero) for orthodontic and restorative dental care. The company operates through two main segments: Clear Aligners, which generate revenue from orthodontic treatment products and related services, and Systems and Services, which include digital scanners, associated software, and support services. Revenue is driven by case volume, product upgrades, and recurring service contracts, with a growing emphasis on digital workflow integration for dental practices and dental service organizations (DSOs).
Performance Analysis
Q1 2024 marked a decisive return to segment outperformance for Align’s Systems and Services business, with revenue surging 17.5% year-over-year, far outpacing the 3.5% growth in Clear Aligners. This segment’s strength was anchored by robust demand for iTero Lumina, next-generation intraoral scanner, and a higher volume of scanner upgrades, particularly in North America. Management noted that CAD/CAM and services now comprise over half of this business, underscoring the shift toward recurring revenue streams.
Clear Aligners sustained moderate growth, with volumes up in APAC and EMEA, while the Americas remained flat. The teen segment set a new record, with nearly 200,000 starts, reflecting resilience in less discretionary demand. Non-case revenues, including Vivera retainers and DSP touch-up cases, also contributed meaningfully, growing 7.5% year-over-year. Margins remained stable, with overall gross margin at 70%, but operating margin compressed sequentially due to higher incentive compensation and stepped-up marketing investment.
- Segment Outperformance: Systems and Services delivered double-digit growth, now contributing a greater share of incremental revenue.
- Stable Demand Profile: Both adult and teen aligner volumes increased sequentially and year-over-year, with regional demand moving in unison.
- Investment-Driven Margin Dynamics: Operating margin dipped sequentially as Align accelerated go-to-market and R&D spending, supporting new product launches and DSO partnerships.
Align’s balance sheet remains robust, supporting continued investments in capacity, innovation, and share repurchases. Free cash flow was positive, and there is no long-term debt, positioning the company to pursue strategic initiatives without financial constraint.
Executive Commentary
"I'm even more excited about Align's innovation in 2024 on our next wave of growth drivers that we believe will continue to revolutionize the orthodontic and dental industry in scanning software and direct 3D printing."
Joe Hogan, President and CEO
"We're making investments...We have new products coming, so that helps us accelerate with things that we'll have on the ITERO side as well as IPE and others that Joe talked about where we really get the approval later in the year. So, you know, it's about a stable environment, making investments into that environment, and then executing on our growth strategies."
John Marucci, CFO
Strategic Positioning
1. Digital Platform Expansion
Align is doubling down on digital workflows by expanding its iTero scanner portfolio and introducing the iTero Lumina platform, which features a wider field of capture and improved ergonomics. This supports higher-value recurring services and strengthens integration with DSOs, a key growth channel.
2. Broadening Clinical Applicability
The Invisalign Palate Expander (IPE) unlocks a previously untapped segment—early interceptive (phase one) orthodontic care—potentially expanding Align’s addressable market by up to 20%. Early clinical data and positive practitioner feedback support the case for long-term adoption, though regulatory rollout will take time.
3. DSO Channel Partnerships
Strategic investments in DSOs, such as Heartland Dental, are intended to accelerate digital adoption and expand Align’s footprint in underpenetrated markets. These partnerships provide both a recurring revenue stream and a proving ground for new digital products and workflows.
4. Global Brand and Consumer Demand Creation
Heavy investment in digital marketing and influencer campaigns is driving record web traffic and engagement, especially among teens and parents. The company’s omnichannel approach—leveraging social media, athlete endorsements, and creative campaigns—supports long-term demand creation and brand strength.
5. Manufacturing and Product Innovation
The acquisition of Cubicure brings proprietary 3D printing technology in-house, enabling Align to scale direct-print appliance manufacturing and reduce production costs over time. This will support future product launches and operational agility.
Key Considerations
This quarter’s results highlight Align’s disciplined execution and willingness to invest ahead of the curve, particularly in digital infrastructure, product innovation, and channel partnerships. The company’s ability to maintain margin discipline while funding these initiatives will be a critical watchpoint for investors.
Key Considerations:
- Systems and Services as a Growth Catalyst: Outperformance in scanners and services signals a durable shift toward recurring revenue and higher-margin business lines.
- Stable Demand Environment: Broad-based stability across geographies and segments de-risks the near-term growth outlook, though macro uncertainties remain.
- DSO Penetration: Expanding DSO partnerships offers a scalable channel for digital adoption, but execution and integration risks persist as the model evolves.
- Innovation Rollout Pace: Regulatory approvals and practitioner adoption of new products like IPE and Lumina will determine the speed of incremental growth.
- Margin Management Amid Investment: Operating leverage must offset elevated R&D and marketing spend to sustain profit growth as new initiatives scale.
Risks
Macro-driven demand volatility, especially in discretionary adult orthodontics, remains a latent risk despite current stability. Foreign exchange headwinds could pressure reported revenue and margin, as signaled by management’s Q2 guidance. Adoption risk for new products like IPE and Lumina, especially outside the US, may delay revenue realization. Execution risk is heightened as Align juggles innovation, channel expansion, and cost discipline in a competitive landscape.
Forward Outlook
For Q2 2024, Align guided to:
- Worldwide revenue between $1.3B and $1.5B
- Sequential growth in clear aligner volume, with ASPs slightly down due to FX
- Systems and services revenue to increase as iTero Lumina ramps
- Operating margin (GAAP and non-GAAP) slightly above Q1 levels
For full-year 2024, management raised guidance:
- Total revenue up 6–8% (previously mid-single digits)
- Incremental revenue split evenly between Clear Aligners and Systems/Services
- Operating margin to improve modestly over 2023
- Capital expenditures targeted at $100M for capacity and innovation
Management emphasized continued stability, execution of new product launches, and expanding DSO partnerships as key growth drivers for the remainder of the year.
- Stable demand environment supports raised outlook
- New products and DSO channel expected to accelerate growth in H2
Takeaways
Align’s Q1 results and upgraded guidance reflect a company entering a new phase of digitally driven growth, with Systems and Services now a primary catalyst. The ability to execute on innovation, expand DSO partnerships, and manage margin amid elevated investment will define the trajectory for the remainder of 2024 and beyond.
- Digital Platform Momentum: Outperformance in scanners and services is shifting the revenue mix toward higher-value, recurring streams, supporting a more resilient business model.
- Innovation and Channel Expansion: New product launches and deeper DSO integration are unlocking incremental growth, but adoption curves and regulatory hurdles must be monitored.
- Watch for Margin Discipline: Investors should track the balance between aggressive investment and operating leverage as innovation and channel strategies scale.
Conclusion
Align’s first quarter underscores a pivot toward digital platform strength and product innovation, backed by stable demand and disciplined execution. The company’s raised outlook is grounded in segment outperformance and a robust innovation pipeline, but ongoing vigilance on adoption rates and cost management is warranted.
Industry Read-Through
Align’s segment acceleration and digital workflow emphasis offer a clear read-through for the broader dental and medtech landscape: Demand for integrated digital solutions is growing, and recurring service models are gaining favor over pure hardware sales. DSOs are increasingly critical as consolidators and digital adoption engines, setting the pace for practice modernization. Competitors in dental imaging, orthodontics, and digital health should expect intensifying product innovation cycles and rising table stakes for channel partnerships and workflow integration. The success of direct 3D printing and early interceptive orthodontics could reshape product roadmaps and market sizing across the industry.